Mayo Clinic's Engineering & Therapeutics in Gastrointestinal Disease Lab is implementing microrobotics in the gastrointestinal tract using a swallowable, remote-controlled robotic capsule.
A new $3.2 million National Institutes of Health (NIH) R01 grant is helping University of Nevada, Reno School of Medicine (UNR Med) researchers delve into one of the body’s most fascinating processes ...
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and is estimated to affect 9.5 million people worldwide. Subscribe to our ...